drugset
drugset / Trial / NCT02520882

68Ga-NOTA-Aca-BBN(7-14) PET/CT in Patients With Primary Gliomas

NCT02520882 ↗

Phase 0 Unknown 30 enrolled Peking Union Medical College Hospital National Institute for Biomedical Imaging and Bioengineering (NIBIB) · collab
NaSingle-groupOpen-labelDiagnostic

Summary

This is an open-label positron emission tomography/computed tomography (PET/CT) study to investigate the diagnostic performance and evaluation efficacy of 68Ga-NOTA-Aca-BBN(7-14) in glioma patients. A single dose of 111-148 Mega-Becquerel (MBq) 68Ga-NOTA-Aca-BBN(7-14) will be injected intravenously. Visual and semiquantitative method will be used to assess the PET/CT images.

Timeline

Start
2015-01
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-NOTA-Aca-BBN Unknown 111 mbq Intravenous
Subject 68Ga-NOTA-Aca-BBN Unknown 148 mbq Intravenous

Indications

glioma